Southwest to Pour $...
Health Care: Drugs
Eli Lilly and Company (LLY: NYSE)
$41.16 0.49 | 1.20%
05/24/12 - 04:00 PM ET
5.63M / 6.07M
Vol / Avg. Vol:40.71 / 40.67
Open / Prev. Close:40.64 - 41.16
Today's Range:33.75 - 42.03
52 Wk Range:-2.14%
Performance YTD:TheStreet Rating:
Portfolios with LLY
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- UserJFleckensteins favorite picks
- Contributor10 Dividend Stocks Held by ...
- UserKAREL VON ZOETE
- ContributorHighest-Yielding Drug Stocks
- ProRenaissance Technologies
- Contributor10 Health Care Stocks to Watch
- Userrp
- ContributorFive Safe, High-Dividend-Yi...
- User2012 pics
Latest LLY Headlines from TheStreet
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- Analysts' Actions: AZO, BMY, LLY, MS 05.18.12 | 09:05 am
- 3 Stocks I Saw on TV, May 18
05.18.12 | 08:05 am - Cramer's 'Mad Money' Recap: A Fulcrum Moment 05.17.12 | 08:05 pm
- Eli Lilly And Company (LLY): Today's Featured Health Care Loser 05.17.12 | 05:05 pm
- Eli Lilly And Stock To Go Ex-dividend Tomorrow (LLY) 05.10.12 | 08:05 am
- Ex-Dividend Stocks: DuPont, AK Steel 05.10.12 | 06:05 am
- Eli Lilly And Company (LLY): Today's Featured Drugs Winner 05.07.12 | 04:05 pm
- Eli Lilly And Company (LLY): Today's Featured Drugs Winner 04.27.12 | 05:04 pm
- Eli Lilly & Co.'s CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.25.12 | 03:04 pm
Press Releases for LLY
- New Phase 3 Data For Tradjenta® (linagliptin) Tablets In Black Or African American Patients With Type 2 Diabetes Showed Significant Improvement In Blood Sugar - PR Newswire 05.24.12 | 09:05 am
- American College Of Endocrinology (ACE) And Lilly Diabetes Offer New Tips To Help People With Diabetes Prepare For Emergencies - PR Newswire 05.23.12 | 09:05 am
- Lilly Diabetes Presents Phase II Blood Pressure And Heart Rate Data On Investigational GLP-1 Analog Candidate, Dulaglutide, In Patients With Type 2 Diabetes At The 27th American Society Of Hypertension Scientific Meeting - PR Newswire 05.22.12 | 08:05 am
- Lilly Oncology To Highlight Final Results For Phase III Study In Most Common Form Of Lung Cancer - PR Newswire 05.14.12 | 09:05 am
- Lilly Applauds Law Enforcement Officials For Their Successful Investigation And Recovery Of Pharmaceuticals Stolen From Connecticut Distribution Center - PR Newswire 05.03.12 | 02:05 pm
- Lilly Sets Date For Lilly Diabetes Pipeline Update To The Investment Community - PR Newswire 05.03.12 | 11:05 am
- DiversityInc Names Lilly A Top Company For Diversity - PR Newswire 04.25.12 | 01:04 pm
- Lilly Declares Second-Quarter 2012 Dividend - PR Newswire 04.16.12 | 03:04 pm
- Lilly Diabetes And Walgreens Launch Diabetes Hypoglycemia Awareness Campaign - PR Newswire 04.16.12 | 10:04 am
- Reintegration Awards Recognize Service To People With Mental Illness - PR Newswire 04.16.12 | 07:04 am
Partner Headlines for LLY
- Lilly's GLP-1 Agonist Delivers - Analyst Blog - Zacks 05.23.12 | 07:05 pm
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- Eli Lilly (LLY) Looks Like A Short - Seeking Alpha 05.11.12 | 09:05 am
- Spectrum: Increased Fusilev Production May Boost Stock - Seeking Alpha 04.30.12 | 09:04 am
- Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics - Press Releases - Zacks 04.27.12 | 09:04 am
- Company News for April 26, 2012 - Corporate Summary - Zacks 04.26.12 | 10:04 am
- The Zacks Analyst Blog Highlights: Apple, Boeing, Eli Lilly, Caterpillar and Sprint - Press Releases - Zacks 04.26.12 | 09:04 am
- Durable Goods Down, Earnings Up - Analyst Blog - Zacks 04.25.12 | 10:04 am
- Ahead of Wall Street - April 25, 2012 - Ahead of Wall Street - Zacks 04.25.12 | 10:04 am
- Earnings Expectations for the Week of April 23 (AAPL, XOM, UPS) - Benzinga 04.22.12 | 11:04 am
